HLS THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.65 CAD | -1.69% |
|
-6.06% | +17.72% |
| 04-08 | HLS Therapeutics Inc. Announces Reduce-IT Analysis Results Relating the Effects of VASCEPA | CI |
| 03-14 | Transcript : HLS Therapeutics Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
Chart calendar HLS Therapeutics Inc.
83314846418a24da96.EfD7v2tsm2kyluGWOc1o9grpKNKniIJQwY_CDeIf2KQ.Jp2y9hwlqRxf2pD8ff0uwj6fcJ6X0rEfluqQf5Zzv51dnKzoWSusOkLA0Q~b537566044503f70c33a03d4c0698ba9
Upcoming events on HLS Therapeutics Inc.
Past events on HLS Therapeutics Inc.
| 17/04/2024 19:00 | Bloom Burton & Co. Healthcare Investor Conference |
| 14/03/2024 12:30 | Q4 2023 Earnings Call |
| 14/03/2024 10:30 | Q4 2023 Earnings Release |
| 09/11/2023 13:30 | Q3 2023 Earnings Call |
| 09/11/2023 11:30 | Q3 2023 Earnings Release |
| 12/09/2023 19:30 | H.C. Wainwright Global Investment Conference |
| 10/08/2023 13:30 | Q2 2023 Earnings Call |
| 10/08/2023 11:30 | Q2 2023 Earnings Release |
| 16/06/2023 15:00 | Annual General Meeting |
| 11/05/2023 13:30 | Q1 2023 Earnings Call |
| 11/05/2023 11:30 | Q1 2023 Earnings Release |
| 26/04/2023 | Ex-dividend day |
| 25/04/2023 16:30 | Bloom Burton & Co Healthcare Investor Conference |
| 16/03/2023 12:30 | Q4 2022 Earnings Call |
| 16/03/2023 10:30 | Q4 2022 Earnings Release |
| 29/01/2023 | Ex-dividend day |
| 16/11/2022 13:35 | Stifel Healthcare Conference - Fireside Chat |
| 10/11/2022 13:30 | Q3 2022 Earnings Call |
| 10/11/2022 11:30 | Q3 2022 Earnings Release |
| 27/10/2022 | Ex-dividend day |
Past dividends on HLS Therapeutics Inc.
| 26/04/2023 | Quarterly 0.05 CAD |
| 29/01/2023 | Quarterly 0.05 CAD |
| 27/10/2022 | Quarterly 0.05 CAD |
| 27/07/2022 | Quarterly 0.05 CAD |
| 27/04/2022 | Quarterly 0.05 CAD |
| 26/01/2022 | Quarterly 0.05 CAD |
| 27/10/2021 | Quarterly 0.05 CAD |
| 28/07/2021 | Quarterly 0.05 CAD |
| 28/04/2021 | Quarterly 0.05 CAD |
| 27/01/2021 | Quarterly 0.05 CAD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 54,2 54,2 -0.15% | 56,1 55,5 1.13% | 60,0 60,9 -1.43% | 61,5 62,9 -2.34% | 63,1 63,2 -0.2% | 64,1 |
|
EBITDA Million USD | Released Forecast Spread | 31,6 31,1 1.72% | 24,1 22,2 8.64% | 26,3 26,3 0.2% | 23,8 24,9 -4.27% | 21,1 20,4 3.03% | 20,3 |
|
EBIT Million USD | Released Forecast Spread | -4,63 -2,72 -70.15% | -12,1 -8,10 -49.22% | -6,28 -6,29 0.12% | -13,5 -12,4 -8.85% | -10,3 -11,9 13.03% | -12,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -16,3 -12,9 -26.15% | -11,8 -12,1 2.53% | -23,7 -21,8 -8.82% | -27,8 -26,9 -3.36% | -21,7 |
|
Net income Million USD | Released Forecast Spread | -19,6 -9,80 -99.55% | -15,3 -11,4 -34.4% | -13,1 -12,3 -6.36% | -23,6 -20,8 -13.28% | -27,5 -26,3 -4.68% | -20,6 |
|
EPS USD | Released Forecast Spread | -0,67 -0,33 -101% | -0,48 -0,37 -31.15% | -0,41 -0,38 -7.89% | -0,73 -0,62 -18.51% | -0,85 -0,78 -8.97% | -0,54 |
| Announcement Date | 19/03/20 | 18/03/21 | 17/03/22 | 16/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 15,7 16,6 -5.67% | 14,6 15,4 -5.6% | 15,5 16,8 -7.54% | 15,7 16,6 -5.4% | 15,7 17,1 -8.35% | 14,8 16,0 -8.01% | 16,4 15,9 3.58% | 16,0 16,3 -1.46% | 15,9 16,1 -1.27% | 14,7 | 15,7 | 16,3 | 17,4 | 17,4 |
|
EBITDA Million USD | Released Forecast Spread | 6,18 6,45 -4.18% | 6,32 6,10 3.54% | 6,16 6,99 -11.88% | 6,02 6,32 -4.81% | 5,34 6,29 -15.18% | 5,08 5,05 0.57% | 5,51 5,63 -2.13% | 5,13 5,43 -5.47% | 5,34 4,97 7.52% | 4,45 | 4,90 | 5,25 | 5,95 | 5,50 |
|
EBIT Million USD | Released Forecast Spread | -2,39 -2,40 0.15% | -2,89 -3,00 3.8% | -3,56 -3,00 -18.7% | -2,94 -3,70 20.46% | -4,11 -3,10 -32.48% | -3,19 -4,20 24.17% | -3,00 -5,70 47.4% | -3,06 -2,40 -27.5% | -1,11 -2,60 57.46% | -3,40 | -3,30 | -3,00 | -2,70 | -2,50 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,52 -3,82 7.9% | -3,55 -4,40 19.3% | -9,15 -4,40 -107.86% | -4,50 -5,10 11.75% | -6,52 -4,60 -41.83% | -5,83 -5,60 -4.14% | -9,32 -7,60 -22.63% | -7,33 -4,30 -70.35% | -5,33 -4,40 -21.05% | -5,80 | -5,60 | -5,40 | -5,00 | -5,00 |
|
Net income Million USD | Released Forecast Spread | -4,19 -3,13 -33.87% | -3,62 -3,50 -3.31% | -9,14 -3,50 -161.23% | -4,41 -4,10 -7.56% | -6,43 -3,60 -78.58% | -5,79 -5,30 -9.28% | -9,44 -6,80 -38.78% | -6,90 -4,10 -68.32% | -5,40 -4,20 -28.6% | -5,50 | -5,30 | -5,10 | -4,80 | -4,70 |
|
EPS USD | Released Forecast Spread | -0,13 -0,10 -30% | -0,11 -0,10 -13.79% | -0,28 -0,07 -319.98% | -0,14 -0,13 -5% | -0,20 -0,07 -172.74% | -0,18 -0,12 -56.52% | -0,29 -0,13 -132% | -0,21 -0,10 -121.05% | -0,17 -0,10 -78.95% | -0,19 | -0,17 | -0,15 | -0,13 | -0,15 |
| Announcement Date | 17/03/22 | 05/05/22 | 11/08/22 | 10/11/22 | 16/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 14/03/24 | - | - | - | - | - |
More events
Past sector events for HLS Therapeutics Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HLS Stock
- Calendar HLS Therapeutics Inc.
